To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women
Condition: OsteoporosisInterventions: Drug: Risedronate/Cholecalciferol combination(montly); Drug: Risedronate/Cholecalciferol combination(weekly)Sponsors: Hanlim Pharm. Co., Ltd.; Hanlim Pharm. Co., Ltd.Recruiting - verified July 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials